Bettina Ryll, MD, PhD of Melanoma Patient Network Europe gives an overview of the sessions by the Melanoma Patient Network Europe held at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark. The sessions covered healthcare system issues and how to ensure best care for patients. Further, Dr Ryll talks about risk sharing agreements or managed entry agreements, i.e. agreements between drug developers and health care providers to grant access to innovative medicines. Dr Ryll believes that by exchanging information and experience between different countries we can better and ensure better access to innovative medicines across Europe.